Oyster Point Pharma, Inc. Retained Earnings
Oyster Point Pharma, Inc. had Retained Earnings of -$389.99 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-11-10
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$389.99M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$353.24M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$303.30M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$255.41M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2022-09-30 | -$389.99M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$353.24M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$303.30M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$255.41M 10-Q · filed 2022-11-10 |
| 2021-09-30 | -$213.35M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$195.68M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$173.66M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$154.75M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$132.52M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$116.21M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$100.75M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$84.23M 10-K · filed 2021-02-18 |
| 2019-09-30 | -$64.51M 10-Q · filed 2019-12-03 |
| 2018-12-31 | -$38.52M 10-K · filed 2020-02-27 |